CASI Pharmaceuticals Inc (CASI)
2.65
-0.04
(-1.49%)
USD |
NASDAQ |
Dec 20, 16:00
2.65
0.00 (0.00%)
Pre-Market: 20:00
CASI Pharmaceuticals Shareholders Equity (Quarterly): 13.85M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Sinovac Biotech Ltd | 8.649B |
| China Pharma Holding Inc | 6.528M |
| Zai Lab Ltd | 667.67M |
| Adagene Inc | 56.59M |
| LakeShore Biopharma Co Ltd | 85.93M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 63.62M |
| Total Liabilities (Quarterly) | 49.77M |
| Debt to Equity Ratio | 1.381 |
| Current Ratio | 3.199 |
| Net Debt Paydown Yield | -4.02% |